Stopping Statins After 75 Shows No Mortality Risk in First Randomized Trial

For generations, medicine has treated the continuation of statins in older patients as a quiet default — a precaution so embedded in routine that the question of stopping was rarely asked. Now, the first randomized controlled trial to examine that question directly has returned a quietly remarkable answer: for adults over 75 at low cardiovascular risk, discontinuing statins produced no meaningful difference in survival over three years. The finding does not overturn the value of these medications where risk is genuine, but it invites a long-overdue reckoning with the difference between treatin